Park City Group Inc

NYSE:TRAK

Earnings Call Analysis

ReposiTrak poised for growth with traceability and strong financials.

In the first quarter of fiscal 2025, ReposiTrak reported an 8% revenue growth to $5.4 million, driven by a 6% increase in recurring revenue. The shift toward traceability is accelerating, with expectations for it to comprise 50% of total revenue in three years. Operating income rose 23% to $1.5 million, and net income grew by 21% to $1.7 million. With over $25 million in cash and no debt, the company has also approved a 10% increase in the quarterly dividend. Management remains confident that by doubling their annual recurring revenue, they will achieve sustained growth while maintaining robust gross margins at 80%.

A Strong Start to Fiscal 2025

In the first quarter of fiscal 2025, ReposiTrak reported total revenue of $5.4 million, marking an 8% increase from the previous year's $5.1 million. This growth was driven largely by a 6% increase in recurring revenue, which now accounts for 98% of total revenues. The results showcase the company's robust operational performance with a net income increase of 21% to $1.7 million and a remarkable 26% rise in net income attributable to common shareholders. The company’s commitment to operational excellence is reflected in its 23% growth in operating income, which rose from $1.2 million to $1.5 million.

Investment in Traceability: A Game Changer

Traceability solutions are becoming increasingly important in the food sector, with ReposiTrak's contribution to total revenue currently standing at 6%. The company anticipates this figure will grow significantly, potentially reaching 50% within three years. Customers already queued for onboarding represent more than $10 million in additional annual recurring revenue expected over the next 18 months. As larger retailers like Walmart, Target, and Kroger enhance traceability requirements, ReposiTrak stands to benefit significantly from the shift, positioning itself as an essential partner in compliance.

Capital Management and Shareholder Returns

ReposiTrak's capital allocation strategy has resulted in a cash reserve of $25.8 million, net of $20 million returned to shareholders through increased dividends and share buybacks. A 10% increase in the quarterly cash dividend to approximately $0.0726 per share was announced, reflecting the Board's commitment to shareholder returns. The company has successfully paid off all bank debts and continues to redeem preferred shares, aiming to retire all of them in the next two years.

Strategic Future and Growth Aspirations

Looking ahead, the company remains optimistic about its growth trajectory, with an outlook of doubling its annual recurring revenue in the next several years while maintaining an 80% gross margin. Management emphasized the importance of flawless execution over rapid expansion, ensuring quality service to customers while capitalizing on the increasing demand for traceability solutions. ReposiTrak is currently onboarding approximately 4,000 companies, which could effectively double the company's size as these clients come online and start generating revenues.

Market Context and Competitive Landscape

The demand for food safety solutions has never been greater, propelled by recent food contamination incidents that have underscored the critical need for traceability in the supply chain. Major retailers pushing for compliance have fundamentally altered the market landscape, making adherence to traceability no longer optional but a requirement for survival. ReposiTrak is well-positioned to capitalize on this shift, offering competitive solutions that exceed regulatory requirements while enhancing food safety across the industry.

Earnings Call Transcript 2025-Q1

[Operator]

Greetings, and welcome to the ReposiTrak Fiscal First Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.

It is now my pleasure to introduce your host, Rob Fink, with FNK IR. Mr. Fink, you may begin.

[Rob Fink]

Thank you, operator, and good afternoon, everyone. Thank you for joining us today for the ReposiTrak Fiscal First Quarter Earnings Call. Hosting the call today are Randy Fields, ReposiTrak's Chairman and CEO; and John Merrill, ReposiTrak's CFO.

Before we begin, I would like to remind everyone that this call could contain forward-looking statements about ReposiTrak within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not subject to historical facts. Such forward-looking statements are based upon current beliefs and expectations. ReposiTrak's remarks are subject to risks and uncertainties, which actual results may differ materially. Such risks are discussed in the company's filings with the Securities and Exchange Commission. The information set forth herein should be considered in light of such risks. ReposiTrak does not assume any obligation to update information contained in this conference call.

Shortly after the market closed today, the company issued a press release overviewing the financial results that will be discussed on today's call. Investors can visit the Investor Relations section of the company's website at repositrak.com to access this press release.

With all that said, I'd now like to turn the call over to John Merrill. John, the call is yours.

[John Merrill, executive]

Thanks, Rob, and good afternoon, everyone. As you know, we communicated just a short time ago, our fiscal 2024 results. Since then, our strategy has not changed, and our September financial results further validates our long-term strategy.

Many of you have asked me when will we see the hockey stick in traceability revenue. As we've always said, we will add customers at a governed pace regardless of opportunity, deadline, product, service or short-term expectation. We will never trade speed for flawless execution, never happen.

As you know, food contamination is front page news almost daily, E.coli, Listeria and Salmonella. Eggs, deli meat, basil, cheeses and even frozen waffles and pancakes, just to name a few. Household names such as McDonald's, Boar's Head, Trader Joe's and BrucePac have all been affected. Big or small, no company is immune to the risk of food contamination.

ReposiTrak's suite of food safety applications to address these issues is unmatched. However, it is a complex multistep process. There's a discovery phase to establish FDA requirements and help a supplier identify what and where the required data lives. Remember, as we communicated before, more than 70% of suppliers do not even have an IT department.

Then there's an evaluation phase, whereby we investigate how we can assist them in extracting the required data. Data is collected in files, in various e-mails written manually or live in one of the suppliers' several systems. Then there is an implementation phase, whereby the data needs to be extracted routinely, stored and forwarded along the supply chain accurately and in accordance with the FSMA 204 requirements.

It is not a one size fits all. It is complex, but that's where we excel. While traceability is top of mind, all of our lines of business deliver a significant customer advantage to make food safer, discovery, supply chain and compliance, which includes traceability.

We have over 100 years of combined management and Board experience in the supply chain and food distribution space. While delivering food safety solutions, our operating philosophy is quite simple: deliver a superior solution at the lowest price with perfect execution, increase recurring revenue in all lines of business, rationalize revenue expansion with cost, expand margins, these include gross margins, operating and net margins, grow net income, grow EPS and provide cash balance even faster, return capital to shareholders. It's a very simple set of concepts, but this requires flawless execution without losing sight of the objective: making food safer.

Our cash balances continue to reach record levels, $25.8 million cash in the bank as of the September quarter. Bear in mind, this is net of the over $20 million in capital returned to shareholders through a growing common stock cash dividend, the redemption of preferred and common shares and paying off all bank debt since we instituted our capital allocation strategy only a few short years ago. This performance comes as we invest significantly in sales, marketing and automation tools to drive the onboarding of traceability customers. The contribution from traceability is only just beginning to impact our overall revenue results, and that contribution continues to accelerate in conjunction with consistent growth and compliance and supply chain offerings.

I remain confident that traceability and growth in our legacy services will double our annual recurring revenue run rate over the next several years, maintaining 80% gross margins, driving higher earnings per share and increased operating cash flow.

Let's get to the September numbers. For the first quarter fiscal 2025, total revenue was up 8%, $5.4 million versus $5.1 million. Recurring revenue increased 6% from $5 million to just under $5.4 million. This was the result of higher subscription revenue and set-up fees due to the increased number of suppliers onboarded during the quarter. Recurring revenue was 98% of total revenue. The decrease from 99% to 98% from the June quarter was a result of higher setup fees due to higher number of supplier onboards, which by nature, are not recurring.

Operating expenses increased 3% to $4 million versus $3.9 million. The increase in OpEx expenses was the result of the ongoing investment in development of automation tools and investment in sales and marketing. Income from operations increased 23% from $1.2 million to $1.5 million. GAAP net income increased 21% to $1.7 million versus $1.4 million. GAAP net income to common shareholders increased 26% from $1.2 million to $1.6 million in fiscal 2025. Basic earnings per share was $0.09 per common share compared to $0.07 per share last year.

During the quarter, our cash generation permitted us to redeem another 70,000 shares of preferred stock at a $10.70 redemption price for just under $750,000. We continue to reiterate our goal to redeem and retire all the preferred shares in the next 2 years.

As we communicated previously, we have paid off all bank debt. Given our strong balance sheet and consistent cash generation, we chose not to renew the $10 million line of credit with the bank. The long-term liabilities we currently maintain are capital leases, which allow us to scale, investing in storage, redundancy systems and upgrades to existing processing capabilities as our needs grow.

This performance comes as just 6% of our total revenue is coming from traceability. We expect the contribution from traceability will increase sequentially throughout fiscal 2025, continuing to accelerate as we approach the January 2026 FDA deadline. Customers are already in the queue to be onboarded over the next 18 months represents more than $10 million in additional annual recurring revenue, or ARR. Obviously, over that same time period, we anticipate adding many more customers to this queue.

We continue to automate to facilitate a faster but moderated enrollment process with a continued goal of improving efficiency. We're getting better and better at this, improving our pace at onboarding suppliers every day.

In summary, our strategy remains very simple. First, we take great care of the customer. As they grow, we grow. Second, we will grow recurring revenue, balancing cost with opportunity. Third, we will manage costs with long-term opportunity. These initiatives will increase net income and EPS.

We generated $1.9 million in cash from operations during the quarter. This is an increase of 23% from the same time period last year. We'll continue to utilize our cash flow to stay away from debt, buy back common and preferred stock and increase the common dividend as cash flow grows. The Board continues to evaluate our capital allocation strategy and may adjust the different capital levers, whichever lever is more favorable to shareholders at that time.

We've increased the cash dividend now twice since the Board of Directors authorized a cash dividend just a short time ago. That's all I have today. Thanks, everyone, for your time.

At this point, I'll pass the call over to Randy. Randy?

[Randall Fields, executive]

Thanks, John. It's really just been a short time since we reported our fiscal fourth quarter results. But since then, tracing all foods, not just FSMA 204, has significantly expanded. Why? Two major catalysts have exerted pressure, along with the approaching deadline. A significant consumer confidence drop in food safety and major retailers moving forward and going past the FDA list has been primary.

The bottom line is that our confidence that traceability will double the size of our company in the next 3 years or so, and more importantly, permanently alter the food industry and in a good way, grow stronger by the day.

Let me add a little color to the catalysts that I've mentioned. First, Walmart and Target have now joined Kroger in announcing that all food suppliers, not just those providing FSMA Rule 204 products, but all food products, will need to provide end-to-end traceability information on or before the January 2026 deadline or product may be refused -- think about that -- refused at the distributor or the store, full stop.

Second, cost and simplicity. Why in the world would you try and separate Rule 204 products from regular products, expand the labor cost and confuse all of your operations? It's easier just to have, honestly, one process.

And third, this whole issue of food safety. Retailers facing obviously highly publicized recalls. Food safety made possible by traceability is critical to their business. It will represent more than just a marketing message. Food safety will become a differentiator for retailers.

Three of the largest retailers have now arrived at the same conclusion: one process, trace it all. It's not surprising that Kroger, Walmart and Target have determined that maintaining two processes, one for the so-called Rule 204 products and one for everything else is simply not practical. Will this be a straight line for everybody doing everything? Well, likely not. Rarely are things running in the straight line.

But overall, we're very comfortable that we've made the right decisions on the basis of the right strategy to position for ultimately, everything being tracked and traced. It will make for a better world.

What does this mean for suppliers? Well, if they want to stay in business, it's pretty simple. They will almost certainly need to comply with traceability requirements, market determined requirements, not FDA requirements. Supplying data in an acceptable format, upstream, downstream as product moves through the supply chain. To be clear, these three big retailers are not our clients, but many of their suppliers are ReposiTrak clients. And ReposiTrak enables suppliers to provide data to those who need to receive it, including major retailers like Kroger, Walmart and Target, just to name a few.

More importantly, this is becoming a massive signal to all suppliers that traceability is not optional. It's the way business will be done. It's a mandate.

The second major new catalyst was a series of terrible recalls. We've all heard about the Listeria outbreaks: Boar's Head, BrucePac, Treehouse, just to name a few. At least a dozen dead and many dozens hospitalized, and potentially hundreds sick. This situation is precisely why the FDA traceability was put in place. Product contamination represents a major risk for retailers and their brands, costing them customers, legal fees and reputation.

Being able to respond quickly, identifying and isolating potential problematic products is obviously essential to their business. And it's only possible with traceability. Otherwise, without detailed traceability, you're throwing the proverbial baby out with the bathwater, meaning that every time there's a contamination issue, you empty your shelves of the product because you have no visibility to a specific lot or batch code that was affected.

The ReposiTrak traceability, in every respect, continues to exceed our expectations. The size and scope of the market continues to grow, in some cases, frankly, exponentially from what we were anticipating. Given the expansion of now three top food retailers to trace all food products, I hope that the time line would be extended by the FDA is becoming less and less relevant every day. As we keep saying, traceability is no longer a regulatory issue. It's a market competitive issue, which is a much stronger pressure from the market perspective.

We don't see the election of President Trump as a risk to traceability at this point. It's too far along, too important major retailers who are dealing with life and death. We continue to hope the deadline is somehow pushed out, so the industry has time to adapt, but we don't anticipate any risk from political change.

To be clear, major retailers are pulling the time line in even more aggressively than the FDA pushed the time line of January 2026. The FDA is unlikely to change those time lines independently that were set by major retailers.

So as more retailers join the early adopters, the FDA's role in driving timing will continue to diminish. Meanwhile, we have and will continue to fine-tune our automation tools to drive more efficiency, enhance cost savings from our scaling. It's actually become a daily activity of ours to focus on changes to our onboarding automation to scale it even faster by making it easier and easier for our customers to self-implement.

Ultimately, remember, there are hundreds of thousands of facilities that will have to learn to do traceability, a brand-new activity they've never done before, and it has to be implemented with a high degree of automation. Our team is the best, literally, not just saying this. Our team is the best that it can be in observing and making changes on a daily basis and having new releases daily to continue to improve our process. It's an obsession of ours. This tuning effort is part of our culture, and it will persist for years.

In compliance management, we've improved our productivity by literally, seriously, a factor of 10, and I suspect we're going to get the same kind of result with our automation for traceability onboarding. Our pace of onboarding continues to get faster and faster. In fact, it's really kind of fun to watch daily.

Frankly, the result is even more than John and I expected in this short period of time. We told you before that it would be picking up? Boy, is it picking up. First, our focus is and always has been on the needs of our customers. That will never change. Traceability is a new process for suppliers and wholesalers and a new operational challenge as well. Our goal is to provide the solution and do it at a price point that encourages widespread industry adoption. This obviously enables us to capture further market share.

We have a business model that is structurally profitable. We've priced the ReposiTrak traceability initiative in line with historical gross margins for our compliance and other offerings, but honestly, it's considered cheap by the user community. Just what we want, perceived as cheap to them and profitable to us.

Second, we've always recognized that there would be add-on services that will drive additional revenue per customer for us, and that will provide tangible value not just for our customer, but earnings for the shareholder.

I'll add more color to this likely in our next earnings call. But keep in mind, bringing the services to market too soon complicates the story, and we're heads down now bringing on thousands upon thousands of suppliers for traceability.

Demand for additional customers to join the RTN is not abating, but actually accelerating. We currently have 4,000 companies representing more or less, we think, 5,000 facilities that are being actively enrolled by our retail and wholesale customers and adding more and more every day. It will take 18 to 24 months to onboard these suppliers and have them all generating revenue. Those 4,000 suppliers that are in hand today that are being required to enroll by their hubs represents about $10 million, more or less, in incremental annualized revenue over the next 24 months.

But while we're onboarding those 4,000, we should certainly add at least that number again to the list, effectively enabling us to double the size of the company as we've been saying over the next few years.

In the first fiscal quarter of 2025, traceability contributed 6% of recurring revenue. We expect this contribution to accelerate throughout the fiscal year, both in terms of recurring revenue and as a percent of our consolidated revenue. Our monthly onboarding is growing rapidly. And when one thinks about the so-called inflection point, it's fair to say, oh, God, I love saying this -- it's fair to say we are inflected.

Over the next year, both the pressure of market forces, continued automation and the absolute number of new hubs is likely to reduce the conversion time from signing the hub to generating revenue from suppliers. We are getting better and better every day, seriously, daily.

While it is clear our urgent focus is on traceability, our Compliance and Supply Chain businesses continue to grow. Our 8% growth in the first fiscal quarter was due to growth in virtually every part of our business. We continue to believe that we can double our annual revenue run rate within the next few years. Our growth must be, however, managed. Otherwise, we will shortchange or confuse our existing customers or do less than our normal superb work for them.

In other words, the current time we find ourselves constrained on growth, not by demand. But the view that management has that each and every implementation has to be handled perfectly. We will not sacrifice quality for speed, not now, not ever. Our business model is simple, it ensures simultaneously delivering success to our customers and consistent growing profitability to our shareholders.

If you look at our financial results, that's self-evident. Operating income was up 23%. Our net income, up 21%, our net income to common shareholders, up 26%, all of that on 8% revenue growth. And frankly, John and I don't see any reason why that phenomenon will not continue. This enables us to return more and more capital to shareholders.

As we announced on the September call, the Board approved another 10% increase in our quarterly cash dividend to what about $0.0726 per share per year. As we continue with our capital allocation strategy announced a few years ago, we've redeemed preferred common, paid off the bank debt, increased the common dividend twice and still have $25 million of cash in the bank.

We have lots more work to do, but I'm incredibly proud of what the team has done so far. We obviously feel very, very good about where we are and how we're positioned for the future.

So with that, I'd now like to open the call for questions. Operator?

[Operator]

Thank you. [Operator Instructions] Our first question comes from Thomas Forte with Maxim Group.

[Thomas Forte, analyst]

Great. So first off, Randy, John, congrats in the quarter. My initial list has five questions. But depending on your answers, I might add one or two. So the first question, I'll go one at a time. Randy, are Walmart, Target and Kroger setting the industry standard or are smaller food retailers unable to follow suit?

[Randall Fields, executive]

Well, my guess is that given those three guys, those three companies have really smart leadership. They saw an opening based on what was happening in the area of food safety. And I think they decided to claim the high ground.

The question is, can smaller companies compete? And the answer is, yes, if they use us, and I don't mean that to sound arrogant. If they use us, they certainly can be at least competitive. But this just changes the landscape. Think of the marketing advantage of being able to say everything you buy from us, everything you buy from us, we'll be able to trace back to its origin. If something happens, we'll be pronto, we'll get the product off the shelf and make it a safer environment.

I think competitively, it's better to do that than say, "Hey, our food might kill you, but it's cheaper." I don't see that. So I think the answer really is, the big guys have established what the market basics are going to be in terms of how to compete. And everybody else over time, will have to find a way to do the same thing.

[Thomas Forte, analyst]

Okay. And then you gave a lot of comments on this question. So I'll try to simplify. 6% of sales in the September quarter were traceability. What could it be in a year?

[Randall Fields, executive]

Well, what you're going to see -- remember, I did say because it was so fun to say, we are inflected. What that implies is that maybe not every single quarter, but probably most quarters, the percentage of our business coming from traceability will be increasing. At some point in the next 3 years, you can fully expect that number goes to 50%. How do we get to that number? It's pretty easy. It's derivative. If we double our revenue in, say, year 3, call it, $40 million of revenue and we have our same $20 million base, that $20 million incremental is all coming from traceability. So it's perfectly reasonable to assume that half of our revenue in 3 years -- 2 to 3 years will come from traceability. And then a couple of years after that, it will probably go even higher.

[Thomas Forte, analyst]

Okay. And then I apologize, some of these are repeats, ones I'd like to ask every quarter. Your current thoughts on adjacent markets? And then I consider restaurants, food adjacent and health care regulatory adjacent?

[Randall Fields, executive]

Well, there's certainly tremendous opportunities in the non-retail food space, and that includes restaurants. It includes all of those outlets, convenience stores where people buy food. But we see those markets as substantially smaller the way we go to market than the retail food business. So we'll inevitably be in those areas by virtue of the fact that the suppliers that we work with sell to both segments. So for example, if you buy products from Kraft, those products could end up being bought and sold in a retail food channel or in a restaurant. So the supplier crossover is very high, which means inevitably, we will be doing business in those industry segments as well.

We just don't see them off the bat as having the same potential. And critically important, just critically important, is for us to keep heads down, be -- I want to be cautious how I say this, be incredibly focused on the customer experience. Something to remember is there's almost nothing our company has done historically that wasn't what I call, improve on the current state.

So for example, when it came to compliance management, did we invent the idea of compliance management? No. But we certainly developed a technology in a way of doing it that was superb by standards of the market. And that's why we're so dominant in that compliance management space.

So almost everything we've done, supply chain, forecasting, ordering has existed, but no one has done traceability before. It's never been done. So it's a space that not only are we -- I'm going to call it, inventing, not only are we incrementing how people think of it, but there's a business reality that people have not done traceability before. So they have to figure out how do we get this into our workflow. How do we get it into our administration system. How do we give them billions of transactions. And by the way, there's going to be -- pick your number, 100 billion transactions that get recorded every year now, 100 billion.

It really doesn't matter what error factor you would apply to that. Let's suppose people are really terrific and the error factor is 2%. We're talking about 20 million errors per year that have to be tracked down, amend it and correct it. So the reality is, this is not something this industry has ever done. So to a certain extent, we're having to deal with -- I'm going to call it the novel nature of it. And we're helping to allow these companies to experiment and ultimately come to grips with the fact that traceability is here to stay, but there are easy ways to do it.

So this is a whole different thing than I think people imagine. There is no traceability that have been done to date, and now everybody is going to have to do it simultaneously. Hopefully, it doesn't look like a goat rodeo, but there's a certain element where people, "Oh, I'll use the blockchain." Well, blockchain my ass. What we need to do is to find a simple, easy way for people to do traceability. We certainly have that. And the fact is that we'll get more than our fair share in the market for helping people be able to track and trace their products.

It's do or die. Seriously, it is do or die. Because if you don't do traceability as a supplier, we weren't kidding where companies are saying, "I can't accept product from you. You can ship it. I just can't accept it." So this is a do-or-die situation. People are going to learn to do it come hell or high water, and we want to be part of that.

[Thomas Forte, analyst]

Okay. So I'm adding a question to my list. So maybe John can answer this one. How should we think of the composition of the growth of the 94% of revenue that wasn't traceability?

[John Merrill, executive]

You mean in terms of Compliance and Supply Chain?

[Thomas Forte, analyst]

Yes. What was one product in particular...

[John Merrill, executive]

Pretty much 50-50. They're complementary, so it's pretty much 50-50.

[Thomas Forte, analyst]

Okay. So you're saying that of the business that wasn't traceability, it performed well as a group. There were no outliers.

[John Merrill, executive]

No, no.

[Thomas Forte, analyst]

Okay. Good. All right. And then capital allocation -- I apologize if this sounds greedy. But you're paying off the preferred, you have a quarterly dividend, and you've historically bought back shares. Under what conditions would we have an end situation where you would pay off the preferred and buy back the common?

[John Merrill, executive]

I don't think our strategy has changed. It is take half the cash from operations, put half in the bank and buy basically either common or preferred or increase the dividend. I think we continue to redeem preferred, that will not change. I think we've done now, call it, $750,000 each quarter for the last, I don't know, 4 or 5 quarters. I don't expect that to change. We just increased the dividend. We have no debt. And obviously, once the preferred is bought back, we would resume the common or increase the dividend.

The capital allocation strategy won't change. Obviously, with the cash generation that we have, it's not a bad problem to have. But we've solved a lot of the things that other companies have, which are debt or complicated cap structure. So I don't believe that will change over the next 2 to 3 years.

And if you look at the mathematics, it's not a forecast, but if you double the size of the company from a revenue standpoint and recurring revenue, then you have no debt, you've paid off the preferred. Obviously, you're doing either M&A, building even more of a focused balance sheet or you're returning more and more capital to shareholders. Sorry for the long-winded answer, but at least Randy was longer than I was.

[Thomas Forte, analyst]

So -- all right, John, I don't know if I heard the number from you. Do you like to give the number on the cost of running the business? Has that changed?

[John Merrill, executive]

Except for -- I've always said it takes $12 million to run the place. Well obviously, with an increase in revenue, you've got more commission, there's payroll taxes that go along with it. We did invest, as you've seen in the sales and marketing, that's not a -- that's an investment for the future. But obviously, as the education increases and your traceability is a household name, we -- I can't tell you how much we have spent in terms of time and dollars educating people on traceability. As that awareness grows, then our expenditures on sales and marketing, I would say, would go back to kind of the pre-education time.

But absent variable costs associated with sales, I maintain the same thing. It takes $12 million to run this place, take the accounting of bad debt and stock comp out of it. It's the same amount. And I don't expect it to grow materially. Will it be up before up 10% in revenue, it grows 2%? I think that's reasonable.

[Thomas Forte, analyst]

All right. And I'm trying to think of the way to phrase this other than the firing the customer away. Can you give your updated thoughts on the efforts you've undertaken to make sure that all your customers are of the highest margin?

[John Merrill, executive]

What does that mean? What do you mean? You mean revenue margin?

[Thomas Forte, analyst]

So John, you've been pretty explicit for, I think, the last, I don't know, 12 to 18 months about churning out of some customers where you weren't getting as favorable margin. I didn't hear that in your prepared remarks. So I just -- I don't know if that means you're done-done? Or -- what does that mean?

[John Merrill, executive]

Well, there's probably...

[Randall Fields, executive]

Let me interject.

[John Merrill, executive]

Go ahead.

[Randall Fields, executive]

We may never be done with that, meaning as a company, we think it's important that our customers experience us successfully and that we experience them successfully. That makes for a relationship.

So over time, it's possible that if we change our offerings, et cetera, we sunset other services, we're brave enough to say it's no longer a good fit with the customer. So over the years, we've been, I think, pretty good about what I call pruning the business to the advantage of the customer, meaning we're leaving you behind because we're going in the different direction.

And then secondarily, from a focus perspective -- and I know this is hard for Wall Street -- by staying focused on fewer things executed hopefully more brilliantly with a higher level of automation, we actually net improve the margins across the business. So we don't have any plans now to do anything. We love where we currently are. You're going to see this -- I love this word -- we be inflected. So as the inflection starts to show up more and more in the numbers, we feel better and better about where we are. But we're brave enough, Tom, if a year from now, it turns out we have some area of the business that doesn't look to have a future, we'll sunset it. It's just our nature. Pruning is a good thing.

[Thomas Forte, analyst]

Okay, Randy. I'll remember pruning for next quarter. All right. And then you like to use the word automation a lot. I'm going to use the sexier word, AI. Do you want to get your quarterly update on your AI efforts?

[Randall Fields, executive]

Yes. Yes. What -- the way we approach a scaling activity is that it's not a people problem. It's a process problem. Now I don't know that that's universally true in the world. But for us, it's always true that when we're trying to scale something, go from doing one a week to one a minute, when we see that as the goal, we assemble our -- literally, our best and brightest, the highest level people in our company will be flabbergasted at the size of the team. It's a significant proportion of our total team. And we pull apart the process. We document every single step to get it done. We work backwards from what's the result of where are we today. And we dissect that. Then we build a tool that leads the customer through that process just as if a human were doing it.

And maybe we're not as smart as we ought to be, but I can tell you that every time we do that, we have to tune it. So literally, I wasn't kidding in my remarks when I said today, we talked about our wizard being introduced or 9 months ago, a year ago, whenever it was. It's out there in the wild. And wow, most companies would say, "Oh, look at this, you've gone from just a few to dozens per day or 100 or 200 a week." But that's not how we think. How we think is every day, every single day, have that team meet, digest what we're doing, figure out what's wrong in the wizard.

In fact, you'll get a kick out of this. Guess what we call the meetings to talk about getting the Wizard better. We call it the baby is ugly. And we start from a pretty negative perspective. Our baby is ugly. We accept that. It can be -- the baby can be way prettier than the baby is today. But you have to start from, it ain't great, it's only pretty good. And day by day, we come up with little things that can change what we're doing to get to an extremely high level of automation. So just -- if you were wishing and hoping and thinking about the future.

We think 1 day -- this is not a forecast. One day, we will have hundreds of thousands of users in traceability. Not 5,000, not 10,000, not 50,000, hundreds of thousands. To get from here to there, we could -- I suppose you'd hire a [ grundle ] of people, you'd end unemployment in India or some place. But what you want is to do it extraordinarily profitably on the one hand, but have each customer have an experience so that at the end of it, they say, "Wow, that was easy." That was easy because easy doesn't seem to exist in today's world.

So conceptually, we keep focusing on the automation tools. We're not adding people to the process. Because for us, nine women in the room for a month do not equal a baby. We want a process that can be run by a customer, managed by a customer to lead to exquisite results. It's a different way of being in the world.

And that's why -- we don't know, but let's say, 3 years from now, we're doing $40 million or $50 million a year. One question you would ask is, well, how many more people do you need to do that? And the answer is, I don't know, a handful, five, maybe six. We will not be scaling the people, we'll be scaling the process. And I know it's a different approach, but it's better for the customer. It's definitely better for the customer. And that's why we do it that way. Did that -- part of that is AI, but not all of it.

[Thomas Forte, analyst]

Okay. So one last question, unless you answer it in a way that I want to ask another one. So can you give your current thoughts on strategic M&A? But I want to add a layer to it. Could you acquire a business to accelerate your onboarding efforts?

[Randall Fields, executive]

We don't think so, not at this point. And the reason is, even if it could, we've got what I call intersectionality problem, meaning suppose we buy something, it takes us a year to integrate it. It distracts us. But a year from now, it triples us. We're going to triple our onboarding in a year without doing anything else.

In other words, it might get in the way, and we can't take the risk. That's really kind of where we are. We cannot take the risk. We can afford the risk. By -- obviously, but it's not worth the risk to the shareholders and more importantly, the customers to try and do more faster by buying a company that says they'll help us.

We're as good at this as anybody in the planet. Seriously. We're already that good. But now I want to go to a whole different level of good, and I think we know how to do that. We've done it before. We did it in our compliance management. Year 1 in compliance management, we had 5 people and we did 200 connections. Next year, we had 10 people, and we did 2,500 connections. And the year after that, we had 10 people, and we did 10,000 connections. So we get scaling load, we get scaling, but it requires automation, not people.

So another company couldn't really bring us a set of tools. Our tools are integral to the applications we have. And it's part of our competitive advantage. It's an amazing development environment that lets us build things quickly and effectively to deploy on behalf of our customers. I'm sorry, I'm not counting, just really good at this.

[Thomas Forte, analyst]

Well, you've successfully taken away my desire to ask another question. Or need.

[Randall Fields, executive]

I'm sorry.

[Thomas Forte, analyst]

Thank you, Randy. Thank you, John.

[Randall Fields, executive]

Thank you.

[John Merrill, executive]

Thanks, Tom.

[Operator]

[Operator Instructions] We have reached the end of the question-and-answer session. At this point, I'd like to turn the call back over to Randy Fields for closing comments.

[Randall Fields, executive]

Operator, thank you. John, thank you. We really feel very good about where we are. We're happy to ask -- to answer any questions as they come up. But we're at the fasten your seatbelts point. So everybody, buckle-up. Thank you.

[John Merrill, executive]

Thanks, everybody.

[Operator]

This concludes today's conference. You may disconnect your lines at this time, and we thank you for your participation.